plerixafor has been researched along with Cardiac Remodeling, Ventricular in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hare, JM; Hatzistergos, KE; Hehre, D; Suguihara, C; Torres, E; Young, KC | 1 |
| Ii, M; Jujo, K; Kamide, C; Klyachko, E; Losordo, DW; Misener, S; Renault, MA; Roncalli, J; Tanaka, T; Thorne, T; Tongers, J | 1 |
| Arai, M; Fujiwara, H; Fujiwara, T; Kobayashi, H; Minatoguchi, S; Misao, Y; Ohno, T; Onogi, H; Takemura, G; Ushikoshi, H | 1 |
| Calderone, A; Clement, R; El-Helou, V; Gillis, MA; Gosselin, H; Proulx, C; Villeneuve, L | 1 |
| Hatake, K; Hongo, M; Ikeda, U; Ise, H; Izawa, A; Morimoto, H; Motoyoshi, K; Shiba, Y; Takahashi, M | 1 |
5 other study(ies) available for plerixafor and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension.
Topics: Animals; Animals, Newborn; Benzylamines; Bone Marrow Cells; Chemokine CXCL12; Cyclams; Heart Ventricles; Heterocyclic Compounds; Humans; Hypertension, Pulmonary; Hypoxia; Infant, Newborn; Infant, Premature; Mice; Pulmonary Circulation; Receptors, CXCR4; Systole; Ventricular Remodeling | 2009 |
Sonic hedgehog-induced functional recovery after myocardial infarction is enhanced by AMD3100-mediated progenitor-cell mobilization.
Topics: Animals; Benzylamines; Cell Movement; Cyclams; Disease Models, Animal; Gene Transfer Techniques; Genetic Therapy; Hedgehog Proteins; Heterocyclic Compounds; Humans; Injections, Intralesional; Injections, Subcutaneous; Mice; Mice, Knockout; Myocardial Infarction; Neovascularization, Physiologic; Random Allocation; Sensitivity and Specificity; Stem Cells; Survival Rate; Treatment Outcome; Ventricular Remodeling | 2011 |
Modification of post-myocardial infarction granulocyte-colony stimulating factor therapy with myelo-suppressives.
Topics: Animals; Apoptosis; Benzylamines; Blood Cell Count; Chemokine CXCL12; Chemokines, CXC; Cyclams; Cyclophosphamide; Drug Therapy, Combination; Echocardiography; Endothelial Cells; Fluorouracil; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Immunosuppressive Agents; Male; Myocardial Infarction; Myocytes, Cardiac; Rabbits; Receptors, CXCR4; Ventricular Remodeling | 2007 |
Antagonism of stromal cell-derived factor-1alpha reduces infarct size and improves ventricular function after myocardial infarction.
Topics: Animals; Benzylamines; Chemokine CXCL12; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling | 2007 |
Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice.
Topics: Animals; Apoptosis; Benzylamines; Cell Differentiation; Cells, Cultured; Chemokine CXCL12; Collagen; Cyclams; Cytokines; Echocardiography; Endothelial Cells; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Humans; Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Receptor, Macrophage Colony-Stimulating Factor; Receptors, CXCR4; Receptors, Granulocyte Colony-Stimulating Factor; Transforming Growth Factor beta1; Ventricular Remodeling | 2007 |